A Study to Evaluate the Bioavailability of Pembrolizumab Via Subcutaneous Injection of MK-3475A In Advanced Solid Tumors
This is a study to assess the pharmacokinetics, safety, and tolerability of pembrolizumab formulated with MK-5180 when administered as a SC injection to participants with advanced solid tumors. Participants will receive